The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …

Objective The 'Atrial fibrillation Better Care'(ABC) pathway has been recently proposed as a
holistic approach for the comprehensive management of patients with atrial fibrillation (AF) …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Background Direct-acting oral anticoagulant use for stroke prevention in atrial fibrillation is
limited by bleeding concerns. Asundexian, a novel, oral small molecule activated …

Description Proton pump inhibitors (PPIs) are among the most commonly used medications
in the world. Developed for the treatment and prevention of acid-mediated upper …

Background Atrial fibrillation is frequently asymptomatic and thus underdetected but is
associated with stroke, heart failure, and death. Existing screening methods require …

BACKGROUND Bleeding is a potential complication after neuraxial and peripheral nerve
blocks. The risk is increased in patients on antiplatelet and anticoagulant drugs. This joint …

This article has been co-published with permission in EP Europace and EuroIntervention. All
rights reserved. VC 2019 the European Heart Rhythm Association and the European …

Importance Atrial fibrillation (AF) is the most common cardiac arrhythmia. The prevalence of
AF increases with age, from less than 0.2% in adults younger than 55 years to about 10% in …

Background: Low detection and nonadherence are major problems in current management
approaches for patients with suspected atrial fibrillation (AF). Mobile health devices may …